PDMR/Director Dealing

/**/

RNS Number : 0386N Premier Miton Group PLC 29 December 2025  

29 December 2025 Premier Miton Group plc ('Premier Miton' or the 'Company') PDMR/Director Dealing   Premier Miton Group plc (AIM: PMI) announces that today it granted nil cost contingent share rights (the 'Awards') over ordinary shares of 0.02p each in the Company (the 'Shares') to certain senior managers and two Directors in accordance with the rules of the 2016 LTIP. Vesting of Awards is subject to continued employment and performance conditions based on Total Shareholder Return, Earnings Per Share, Assets under Management and other M&A and operational conditions, all measured over a three-year performance period ending 30 September 2028. Awards are subject to malus and clawback provisions.   The notification below, made in accordance with the requirements of UK Market Abuse Regulation, provides further detail.  

1.

Details of PDMR / person closely associated with them ('PCA')

a)

Name

Michael O'Shea

2.

Reason for the notification

a)

Position / status

Director

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Premier Miton Group plc

b)

LEI

213800LK2M4CLJ4H2V85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of financial instrument Identification Code

Ordinary Shares of 0.02p each in Premier Miton Group plc ISIN: GB00BZB2KR63  

b)

Nature of the transaction

Grant of nil cost contingent shares in accordance with the 2016 LTIP rules  

c)

Price(s) and volume(s)



Price(s)



Volume(s)

Nil



816,000 Shares









d)

Aggregated information Aggregated volume Price

N/A single transaction

e)

Date of the transaction

29 December 2025  

f)

Place of the transaction

Outside a trading venue

   

1.

Details of PDMR / person closely associated with them ('PCA')

a)

Name

Piers Harrison

2.

Reason for the notification

a)

Position / status

Director

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Premier Miton Group plc

b)

LEI

213800LK2M4CLJ4H2V85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of financial instrument Identification Code

Ordinary Shares of 0.02p each in Premier Miton Group plc ISIN: GB00BZB2KR63  

b)

Nature of the transaction

Grant of nil cost contingent share award in accordance with the 2016 LTIP rules  

c)

Price(s) and volume(s)



Price(s)

Volume(s)

Nil

425,000 Shares









d)

Aggregated information Aggregated volume Price

N/A single transaction

e)

Date of the transaction

29 December 2025  

f)

Place of the transaction

Outside a trading venue

  For further information, please contact:   Enquiries:

Premier Miton Group plc Mike O'Shea, Chief Executive Officer  

  01483 306 090  

Investec Bank plc (Nominated Adviser and Broker) David Anderson / Ben Griffiths / St John Hunter    

  020 7597 4000  

Camarco Geoffrey Pelham-Lane / Ben Woodford  

  07733 124 226 / 07990 653 341

KK Advisory Ltd Steve Keeling / Kam Bansil  

  020 7039 1901

  Notes to editors: Premier Miton Investors is focused on delivering good investment outcomes for investors through relevant products and active management across its range of investment strategies, which include equity, fixed income, multi-asset and absolute return.   LEI Number: 213800LK2M4CLJ4H2V85    

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  DSHTLBRTMTMTBMA